Gladstone NOW: The Campaign Join Us on the Journey ✕
46 - 60 of 130 Results Clear All
Armed with a $26.5-million grant, a multi-institution collaboratory will tackle HIV in a new way
Grants News Release HIV/AIDS Infectious Disease Ott Lab CRISPR/Gene Editing
New analysis suggests the California variant is more transmissible than unmutated strains, but vaccines are effective against it
News Release Research (Publication) COVID-19 Infectious Disease Ott Lab
While the practice of placing papers on preprint servers ahead of peer review remains controversial in the scientific community worldwide, many Gladstone investigators are using bioRxiv to advance their research and get information out more quickly
Gladstone Experts COVID-19 Krogan Lab McDevitt Lab Ott Lab Pollard Lab
ABC7 News—Senior Investigator Melanie Ott, PhD, Director of the Gladstone Institute of Virology, talks about the long path to leadership and recognition for women in medicine.
COVID-19 Infectious Disease Ott Lab
San Francisco Business Times—Senior Investigator Melanie Ott, MD, PhD, and Graduate Student Parinaz Fozouni explain how the CRISPR- and smartphone-based diagnostic platform they recently developed with UC Berkeley Dan Fletcher, PhD, and Nobel Laureate Jennifer Doudna, PhD, could allow low-cost and widespread testing and help to quickly curb the course of this and future pandemics.
COVID-19 Infectious Disease Doudna Lab Ott Lab CRISPR/Gene Editing
Gladstone scientists discover how the novel coronavirus damages heart muscle cells, and create a system that can be used to screen potential therapies
News Release Research (Publication) COVID-19 Cardiovascular Disease Infectious Disease Conklin Lab McDevitt Lab Ott Lab
The Mercury News—Director of Gladstone Institute of Virology Melanie Ott, MD, PhD, comments on the new coronavirus variants and says vaccines currently distributed in the US protect against hospitalization and death from COVID-19.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
San Francisco Business Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, is one of several key Bay Area women life scientists sharing their views on their careers, the pandemic, and the path ahead for women leaders.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
A Gladstone discovery could be selected as the top innovation in biomedicine
Awards COVID-19 Doudna Lab Krogan Lab Ott Lab CRISPR/Gene Editing
San Francisco Chronicle—New coronavirus variants are emerging around the world, including in the Bay Area. Melanie Ott, director of the Gladstone Institute of Virology, explains that if the vaccine rollout isn’t fast enough, viral variants that can evade the vaccine may become prevalent, rendering the vaccine partially ineffective.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
ABC7 News—Gladstone Institute of Virology Director Melanie Ott, MD, PhD, and Graduate Student Parinaz Fozouni comment on the COVID-19 detection test they recently developed with Nobel Laureate Jennifer Doudna, PhD, and UC Berkeley Professor Dan Fletcher, PhD, using CRISPR and smartphone technology.
Gladstone Experts COVID-19 Infectious Disease Doudna Lab Ott Lab CRISPR/Gene Editing
Melanie Ott helped shape recommendations for a unified plan to end the pandemic
Gladstone Experts COVID-19 Ott Lab
Forbes—In an article about the need for rapid testing to monitor and curb the COVID-19 pandemic, Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, explains the advantages of the CRISPR- and smartphone-based detection platform she developed with Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, and UC Berkeley Professor Dan Fletcher, PhD.
Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Doudna Lab Ott Lab
San Francisco Business Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, discusses the rapid, smartphone-based Coronavirus detection assay her group recently described in the scientific publication Cell. The assay was developed by Graduate Student Parinaz Fozouni, in collaboration with the labs of Senior Scientist and Nobel Laureate Jennifer Doudna, PhD, and of UC Berkeley Bioengineering Professor Dan Fletcher, PhD.
Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Doudna Lab Ott Lab
The new study points toward ways to treat not only COVID-19, but future coronaviruses that might emerge
News Release Research (Publication) COVID-19 Infectious Disease Krogan Lab Ott Lab
